313 related articles for article (PubMed ID: 31838177)
1. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway.
Hosseini H; Teimouri M; Shabani M; Koushki M; Babaei Khorzoughi R; Namvarjah F; Izadi P; Meshkani R
Int J Biochem Cell Biol; 2020 Feb; 119():105667. PubMed ID: 31838177
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
[TBL] [Abstract][Full Text] [Related]
3. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
5. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
6. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
[TBL] [Abstract][Full Text] [Related]
7. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
[TBL] [Abstract][Full Text] [Related]
8. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
9. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
10. Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway.
Zhang X; Ji R; Sun H; Peng J; Ma X; Wang C; Fu Y; Bao L; Jin Y
Free Radic Res; 2018 Feb; 52(2):198-211. PubMed ID: 29400110
[TBL] [Abstract][Full Text] [Related]
11. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
[TBL] [Abstract][Full Text] [Related]
12. Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy.
Yu H; Yan S; Jin M; Wei Y; Zhao L; Cheng J; Ding L; Feng H
Phytomedicine; 2023 May; 113():154746. PubMed ID: 36905866
[TBL] [Abstract][Full Text] [Related]
13. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
[TBL] [Abstract][Full Text] [Related]
15. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease.
Shimpi PC; More VR; Paranjpe M; Donepudi AC; Goodrich JM; Dolinoy DC; Rubin B; Slitt AL
Environ Health Perspect; 2017 Aug; 125(8):087005. PubMed ID: 28796629
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
[TBL] [Abstract][Full Text] [Related]
18. PSA controls hepatic lipid metabolism by regulating the NRF2 signaling pathway.
Huang B; Xiong X; Zhang L; Liu X; Wang Y; Gong X; Sang Q; Lu Y; Qu H; Zheng H; Zheng Y
J Mol Cell Biol; 2021 Oct; 13(7):527-539. PubMed ID: 34048566
[TBL] [Abstract][Full Text] [Related]
19. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates rotenone-induced inflammation and oxidative stress via STAT1 and Nrf2/Keap1/SLC7A11 pathway in a microglia cell line.
Li H; Shen Y; Xiao H; Sun W
Pathol Res Pract; 2021 Sep; 225():153576. PubMed ID: 34391968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
